Polyene Phosphatidylcholine

多烯磷脂酰胆碱

Report date: 2023/03/23 14:18:12
NME

Base Information

Drug NamePolyene Phosphatidylcholine
Drug Alias NamePolyenephosphatidyl choline易善复EPLEssentiale N
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsMarijuana UseHepatitis, ChronicHepatitis +[6] 
Global Approved IndicationsHepatitis, ChronicHepatitisHepatic Insufficiency +[5] 
Approved Indications in ChinaHepatitisHepatic InsufficiencyFatty Liver +[4] 
Original Approved Country/TerritoryJapan
Original Approved Date1968/01/01
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSanofiAlfresa Pharma
China Registration ClassN/A

Develop Information

Active CompaniesAlfresa PharmaSanofiUniversity Of Colorado Denver
Inactive CompaniesN/A
Active IndicationsMarijuana UseHepatitis, ChronicHepatitis +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeA05A
Related LinksKEGG